Edit
ForSight VISION5
http://www.forsightv5.com/Last activity: 16.04.2014
Active - Reference to Viekira Pak
ForSight VISION5, Inc. was founded in January of 2011 as the fifth company to emerge from the ophthalmic incubator ForSight Labs, LLC (www.forsightlabs.com). ForSight VISION5 is focused on developing non-invasive products that replace eye drops and provide sustained therapy for major anterior segment eye diseases including glaucoma, dry eye, and allergy. ForSight VISION5’s lead product candidate is the Helios insert, a novel, non-invasive delivery system designed to allow glaucoma and ocular hypertensive patients to continually receive medication.
For more information visit:
For more information visit:
Total raised: $15M
Investors 2
| Date | Name | Website |
| - | H.I.G. Cap... | higcapital... |
| - | H.I.G. Bio... | higbio.com |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 16.04.2014 | Series C | $15M | - |
Mentions in press and media 2
| Date | Title | Description |
| 16.04.2014 | ForSight VISION5 Completes $15M Series C Financing | ForSight VISION5, a Menlo Park, CA-based developer of non-invasive products to replace eye drops and provide sustained therapy for major anterior segment eye diseases including glaucoma, dry eye, and allergy, completed a $15m Series C finan... |
| 16.04.2014 | ForSight VISION5 Sees $15M Series C Funding | MENLO PARK, CA, ForSight VISION5 has completed its Series C financing which raised $15 million and was led by H.I.G. BioVentures. >> Click here for more funding data on ForSight VISION5 >> To export ForSight VISION5 funding ... |